# Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

> **NCT00143884** · PHASE2 · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 30 (—)

## Conditions studied

- Leukemia
- Lymphoma, Low-Grade
- Lymphoma, Non-Hodgkin's
- Multiple Myeloma
- Myelodysplastic Syndromes

## Interventions

- **PROCEDURE:** Reduced intensity conditioning
- **PROCEDURE:** Prophylactic donor leukocyte infusions

## Key facts

- **NCT ID:** NCT00143884
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (—)
- **Last updated:** 2007-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143884, "Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00143884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*